Venture Life Group (VLG) Repurchases 45,459 Shares at 66.00p in AIM Buyback Scheme

Venture Life Group plc (AIM: VLG), a UK-based international consumer self-care firm specialising in product innovation and global healthcare commercialisation, confirmed the acquisition of 45,459 ordinary shares at a volume-weighted average price of 66.00 pence per share on 4 September 2026. This transaction was completed via Cavendish Capital Markets Limited under the share buyback programme announced on 20 August 2026. The repurchased shares will be held in treasury, lowering the total voting rights in the company to 119,924,862. Key Points Venture Life Group plc (AIM: VLG) — an international consumer self-care company headquartered in the UK On 4 September 2026, the company bought 45,459 ordinary shares of 0.3 pence each at 66.00 pence per share Total shares issued now amount to 128,860,145, with 8,935,283 shares held in treasury; voting rights stand at 119,924,862 Investors should monitor for additional buyback transactions under the programme announced on 20 August 2026 The full block of 45,459 ordinary shares was acquired in one transaction at a uniform price of 66.00 pence per share at 16:23 on 4 September 2026. This was executed on the AIMX platform through Cavendish Capital Markets Limited, the company's nominated adviser and broker. The identical lowest, highest, and volume-weighted average price of 66.00 pence confirms all shares were purchased at a consistent single price. This buyback forms part of the capital management strategy announced on 20 August 2026. Treasury Shares and Voting Rights Update Post-Repurchase After this repurchase, Venture Life holds 8,935,283 ordinary shares in treasury from a total issued share capital of 128,860,145 shares. Since treasury shares do not carry voting rights, the company's total voting rights denominator is now 119,924,862. This figure is critical for shareholders to determine if they must notify changes in their holdings under the FCA's Disclosure Guidance and Transparency Rules, a key regulatory consideration for institutional and significant shareholders. VLG's Consumer Self-Care Range Covers Women's Health, ENT, Energy, and Hormonal Lifecycle Products Headquartered in the UK, Venture Life operates internationally in the consumer self-care sector with products such as Balance Activ for women's intimate healthcare, Earol® for ENT care, Lift and Glucogel for energy and glucose management, and the Health & Her range supporting the hormonal lifecycle. These products are generally recommended by pharmacists or healthcare professionals and distributed through health and beauty retailers, pharmacies, grocery chains, and e-commerce worldwide. The company supplies retailers directly in the UK, Ireland, and the USA, while international markets are served via distribution partners. To keep reading, please log in to your account, create a free account, or simply fill out the form below.